SCHEMBL1635104

SCHEMBL1635104

C1#CCCCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14362121 1.00
SCHEMBL16534583 1.00
SCHEMBL10527801 1.00
SCHEMBL563490 1.00
SCHEMBL3756290 1.00
SCHEMBL180919 1.00
SCHEMBL1139908 1.00
SCHEMBL3198984 1.00
SCHEMBL585520 1.00
SCHEMBL1140387 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250367314-A1 LINKER-PAYLOAD, AN ANTIBODY-DRUG CONJUGATE MADE THEREBY AND USES THEREOF Chien, Du-Shieng (US) 2025-12-04 US claimed
EP-4642491-A1 METHOD FOR GLYCOPROTEIN MODIFICATION Honeybear Biosciences Inc. (TW) 2025-11-05 EP claimed
US-20240392041-A1 Site-Specific Crosslinking of Antibodies LIFE TECHNOLOGIES CORP (US) 2024-11-28 US claimed
US-12071487-B2 Site-specific crosslinking of antibodies Life Technologies Corporation (US) 2024-08-27 US claimed
US-20240238432-A1 METHOD FOR GLYCOPROTEIN MODIFICATION HONEYBEAR BIOSCIENCES INC. (TW) 2024-07-18 US claimed
US-20230135545-A1 BIOMIMETIC G-QUARTET COMPOUNDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-05-04 US claimed
WO-2023048505-A1 APN GROUP-BEARING LINKER AND FUNCTIONAL POLYPEPTIDE VARIANT-ALBUMIN CONJUGATE PREPARED USING SAME 주식회사 프로앱텍 2023-03-30 WO claimed
EP-4126865-A1 BIOMIMETIC G-QUARTET COMPOUNDS Centre national de la recherche scientifique (FR) 2023-02-08 EP claimed
CN-110382404-B Nanoparticles 奈德公司 2022-07-08 CN claimed
EP-4736896-A1 BIOCOMPATIBLE DEVICE Mochida Pharmaceutical Co., Ltd. (JP) 2026-05-06 EP disclosed
WO-2026088116-A1 BALLOON CATHETER NANOMEDX, INC. (US) 2026-04-30 WO disclosed
EP-4731602-A1 NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS OZ Biosciences (FR) 2026-04-29 EP disclosed
EP-4724605-A1 CAPTURING AND AMPLIFYING POLYNUCLEOTIDES, AND REUSING FLOWCELLS, USING SILICA PARTICLES Illumina, Inc. (US) 2026-04-15 EP disclosed
US-12576156-B2 Compound comprising self-immolative group and ligand-drug conjugate comprising same TRIOAR, INC. (KR) 2026-03-17 US disclosed
WO-2000043459-A1 CORROSION-INHIBITING COATING COMPOSITIONS FOR METALS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-07-27 WO disclosed
US-5993690-A Organosilicon compound, liquid crystal composition, and liquid-crystal display element CHISSO CORPORATION (JP) 1999-11-30 US disclosed
US-5932642-A Cyclic phosphinic acid derivatives as stabilizers CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-08-03 US disclosed
EP-0897958-A1 Stabilisers for powder coatings Ciba SC Holding AG (CH) 1999-02-24 EP disclosed
EP-0872484-A1 ORGANOSILICON COMPOUNDS, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT CHISSO CORPORATION (JP) 1998-10-21 EP disclosed
EP-0850946-A1 Cyclic phosphinic acid derivatives as stabilizers Ciba SC Holding AG (CH) 1998-07-01 EP disclosed